 |
 |
 |
 |
 |
 |
Structural Genomics Consortium at the University of Toronto Welcomes Hui Peng
Toronto, March 27, 2024 – The Structural Genomics Consortium (SGC) is pleased to announce Dr. Hui Peng has joined the SGC-Toronto as a Principal Investigator.
Dr. Hui Peng, PhD, is an Associate Professor in the Department of Chemistry at the University of Toronto. He is an internationally recognized expert in analytical and environmental chemistry and the recipient of multiple awards, including the Ontario Early Researcher Award (2022), the James J. Morgan Early Career Award of the American Chemical Society (ACS, 2023), Canadian Society for Chemistry (CSC) Early Career Research Award (2024).
In his new role at SGC, Dr. Peng will spearhead the development of an ASMS screening platform. This scalable platform will have the capability to interrogate thousands of human proteins, while also generating open protein-ligand data to be used in the development of machine-learning models. The main objective of the project is to develop and apply models that can predict effective and selective small molecule binders for thousands of human proteins.
“We are thrilled to have Hui Peng lead the development and scaling of ASMS at SGC, especially in times when high-quality data is critical for the future of computational drug discovery”, said Dr. Cheryl Arrowsmith Chief Scientific Officer at SGC-Toronto. “ASMS is a screening platform that is deployed in most pharmaceutical companies but not in academia due to the large upfront investment it requires, and the requirement for high-quality protein samples. We are now one of the handful of academic research hubs in the world with ASMS screening capacity and the proteins to feed into it.”
For media inquiries, please contact:
Sofia Melliou
Research Communication Specialist
About the Structural Genomics Consortium (SGC)
The Structural Genomics Consortium is a global public-private partnership that seeks to accelerate drug discovery by fostering collaboration among a large network of scientists in academia and industry and making all research outputs openly available to the scientific community. The current SGC research sites are located at Goethe University in Frankfurt, Karolinska Institute, McGill University, University College, London, the University of North Carolina, Chapel Hill, and the University of Toronto.